Cholinoceptor‐mediated effects on glycerol output from human adipose tissue using in situ microdialysis
Open Access
- 1 August 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 115 (7), 1155-1162
- https://doi.org/10.1111/j.1476-5381.1995.tb15018.x
Abstract
1 Possible cholinoceptor-mediated effects on lipolysis were investigated in vivo in human subcutaneous adipose tissue of non-obese, non-smoking, healthy subjects, by use of microdialysis. Cholinomimetic and sympathomimetic agents were added to the ingoing dialysate solvent. 2 Addition of nicotine to the perfusion solvent caused a concentration-dependent reversible increase in the levels of glycerol in the dialysate (lipolysis index). The opposite effect (also concentration-dependent and reversible) was caused by the addition of carbachol. The maximum effects were 100% stimulation and 50% inhibition, respectively, by nicotine and carbachol. Neither nicotine nor carbachol stimulated nutritive blood flow in adipose tissue (as measured with an ethanol escape technique). 3 The nicotine effect in situ was concentration-dependently counteracted by the nicotinic cholinoceptor antagonist, mecamylamine. Likewise, the carbachol effect was concentration-dependently counteracted by the muscarinic cholinoceptor antagonist, atropine. 4 When adipose tissue was pretreated with phentolamine plus propranolol in order to obtain a complete α and β-adrenoceptor blockade, the subsequent addition of nicotine or carbachol still induced an increase and decrease in dialysate glycerol levels (lipolytic or antilipolytic effects), respectively. When adipose tissue was pretreated with mecamylamine or atropine, the subsequent addition of acetylcholine caused a reversible decrease and increase, respectively, of the dialysate glycerol levels. 5 Nicotine and carbachol had no effects on glycerol release from human isolated subcutaneous fat cells that were incubated in vivo. 6 In conclusion, the data demonstrate a dual effect of the cholinoceptor system on glycerol output in human adipose tissue: stimulation through nicotinic receptors and inhibition through muscarinic receptors. These effects, which are not observed in vitro, are independent of the adrenergic system and the local blood flow and seem not to be mediated by a direct action on the fat cell.Keywords
This publication has 37 references indexed in Scilit:
- Structure/function relationships of muscarinic acetylcholine receptorsLife Sciences, 1993
- Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.Journal of Clinical Investigation, 1993
- Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.Journal of Clinical Investigation, 1992
- G‐protein linked receptors: a family probed by molecular cloning and mutagenesis proceduresClinical Endocrinology, 1992
- Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptorsTrends in Pharmacological Sciences, 1991
- Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: dialysate glucose concentration is blood‐flow‐dependentActa Physiologica Scandinavica, 1991
- Adrenergic regulation of lipolysis in situ at rest and during exercise.Journal of Clinical Investigation, 1990
- Analysis of serial measurements in medical research.BMJ, 1990
- Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitroLife Sciences, 1990
- Determination of Brain Interstitial Concentrations by MicrodialysisJournal of Neurochemistry, 1989